Telix Pharmaceuticals Ltd SEC filings TLPPF
Telix Pharmaceuticals Ltd has 109 filings in SEC EDGAR's recent list, going back to Jan 25, 2024. Its latest annual report, Form 20-F, was filed on Feb 20, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 29, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 20-F/A | Amended annual report (foreign issuer) | Mar 20, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Feb 20, 2026 | Dec 31, 2025 |
| 20-F | Annual report (foreign issuer) | Feb 24, 2025 | Dec 31, 2024 |
Showing 3 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TLX (Nasdaq), TLPPF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Australia
- Headquarters
- North Melbourne, Australia
- SEC filer status
- Large accelerated filer
- SEC CIK
- 2007191
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.